The AR, PI3K-AKT-mTOR, mitogen-activated protein kinase (MAPK), and Wnt-signaling pathways have also been shown to synergistically engage with one another to promote the proliferation and therapeutic resistance of the PCA cells [156,157,158,159]. The gene discussed is AKT1; the disease is posterior cortical atrophy.